drugset / Trial / NCT01209780
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will evaluate the safety and immunogenicity in healthy children and adolescents after one or two IM dose(s) of trivalent subunit inactivated flu vaccine.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-03
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Comparator TIV | Vaccine | — | Intramuscular |
| Comparator | Fluvirin | Vaccine | — | Intramuscular |
| Subject | TIV | Vaccine | — | Intramuscular |